Saltar al contenido
Saltar al contenido

Regulatory management option analysis

The regulatory management option analysis (RMOA) list includes substances for which an RMOA either is under development or has been completed since the start of the implementation of the SVHC Roadmap in February 2013.

For each substance, the table shows the assessing Member State (submitter), the concern, the outcome and the suggested follow-up from the RMOA, and the date of the latest update to the list entry.

Other process details and relevant documents are also available and can be accessed through the ‘Details’ icon for the list entry.

 

Disclaimer to the RMOA list

The responsibility for the content of an RMOA rests with the authority that developed it. It is possible that other authorities do not have the same view, and even develop a further RMOA. Any authority can consequently initiate a regulatory process but should indicate this by appropriate means, such as the Registry of Intentions.

RMOAs and their conclusions are compiled based on available information and may change in light of new information or further assessment.

Last updated 12 agosto 2019. Database contains 221 unique substances/entries.
Filter the list
Latest update:
Date of intention:
Date of RMOA conclusion:

 
201-152-2
78-87-5
Netherlands
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
09/11/2017
Details
214-946-9
1222-05-5
France
Endocrine disruption
Under development
Under development
No suggestion yet
09/08/2019
Details
203-439-8
106-89-8
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
23/09/2014
Details
214-012-0
1072-63-5
Sweden
Toxic for reproduction
Under development
Under development
No suggestion yet
10/04/2018
Details
205-028-9
131-55-5
Denmark
Endocrine disruption
Under development
Under development
No suggestion yet
23/09/2014
Details
426-040-2
-
Netherlands
Bioaccumulation
Other human toxicity
Persistence
Under development
Under development
No suggestion yet
23/09/2014
Details
205-029-4
131-56-6
Denmark
Endocrine disruption
Under development
Under development
No suggestion yet
23/09/2014
Details
422-600-5
-
Germany
Bioaccumulation
Other environmental toxicity
Persistence
Under development
Under development
No suggestion yet
05/12/2014
Details
274-570-6
70321-86-7
Germany
Endocrine disruption
Persistence
Under development
Under development
No suggestion yet
05/12/2014
Details
221-573-5
3147-75-9
Germany
Bioaccumulation
Other environmental toxicity
Persistence
Under development
Under development
No suggestion yet
05/12/2014
Details
603-051-2
125304-04-3
Germany
Bioaccumulation
Other human toxicity
Persistence
Under development
Under development
No suggestion yet
01/04/2015
Details
219-470-5
2440-22-4
Germany
Other human toxicity
Persistence
Toxic for reproduction
Under development
Under development
No suggestion yet
05/12/2014
Details
201-289-8
80-54-6
Sweden
Toxic for reproduction
Under development
Under development
No suggestion yet
27/03/2019
Details
211-765-7
693-98-1
Sweden
Toxic for reproduction
Under development
Under development
No suggestion yet
10/04/2018
Details
201-025-1
77-40-7
France
Endocrine disruption
Under development
Under development
No suggestion yet
07/03/2017
Details
226-378-9
5384-21-4
France
Endocrine disruption
Persistence
Toxic for reproduction
Widespread use
Under development
Under development
No suggestion yet
11/03/2016
Details
210-658-2
620-92-8
Sweden
Endocrine disruption
Other human toxicity
Under development
Under development
No suggestion yet
01/10/2015
Details
201-250-5
80-09-1
Belgium
Carcinogenic
Endocrine disruption
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
06/03/2015
Details
202-681-1
98-56-6
Netherlands
Carcinogenic
Under development
Under development
No suggestion yet
09/11/2017
Details
400-370-7
-
Finland
Bioaccumulation
Other environmental toxicity
Persistence
Under development
Under development
No suggestion yet
10/04/2019
Details
217-533-1
1879-09-0
France
Carcinogenic
Mutagenic
Skin sensitiser
Toxic for reproduction
Under development
Under development
No suggestion yet
07/03/2017
Details
235-715-9
12607-70-4
France
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
23/09/2014
Details
201-469-6
83-32-9
France
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
11/12/2015
Details
287-477-0
85535-85-9
Germany
Carcinogenic
Toxic for reproduction
Under development
Under development
No suggestion yet
08/07/2019
Details
-
-
Netherlands
Carcinogenic
Exposure
Mutagenic
STOT RE
Under development
Under development
No suggestion yet
13/04/2017
Details
215-133-1
1304-56-9
Netherlands
Carcinogenic
Under development
Under development
No suggestion yet
09/11/2017
Details
223-445-4
3896-11-5
Germany
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
05/12/2014
Details
207-069-8
431-03-8
Netherlands
Carcinogenic
Under development
Under development
No suggestion yet
09/11/2017
Details
215-607-8
1333-82-0
Netherlands
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
03/05/2019
Details
231-786-5
7727-54-0
France
Respiratory sensitiser
Skin sensitiser
Under development
Under development
No suggestion yet
13/04/2017
Details
258-649-2
53585-53-8
Finland
Bioaccumulation
Other environmental toxicity
Persistence
Under development
Under development
No suggestion yet
10/04/2019
Details
245-152-0
22673-19-4
Sweden
Toxic for reproduction
Under development
Under development
No suggestion yet
25/10/2018
Details
242-555-3
18755-43-6
Ireland
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
07/03/2017
Details
231-781-8
7727-21-1
France
Respiratory sensitiser
Skin sensitiser
Under development
Under development
No suggestion yet
13/04/2017
Details
231-892-1
7775-27-1
France
Respiratory sensitiser
Skin sensitiser
Toxic for reproduction
Under development
Under development
No suggestion yet
13/04/2017
Details
203-473-3
107-21-1
Netherlands
Carcinogenic
Endocrine disruption
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
09/11/2017
Details
308-208-6
97925-95-6
Netherlands
Toxic for reproduction
Under development
Under development
No suggestion yet
09/11/2017
Details
200-001-8
50-00-0
France
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
04/08/2016
Details
203-856-5
111-30-8
Sweden
Respiratory sensitiser
Skin sensitiser
Under development
Under development
No suggestion yet
08/07/2019
Details
201-143-3
78-79-5
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
07/11/2016
Details
215-204-7
1313-27-5
Denmark
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Under development
Under development
No suggestion yet
19/12/2016
Details
225-625-8
4979-32-2
Germany
Bioaccumulation
Exposure
Persistence
Widespread use
Under development
Under development
No suggestion yet
28/02/2019
Details
242-522-3
18718-11-1
France
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
23/09/2014
Details
231-743-0
7718-54-9
France
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
23/09/2014
Details
235-008-5
12054-48-7
France
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
23/09/2014
Details
236-068-5
13138-45-9
France
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
23/09/2014
Details
205-355-7
139-13-9
Ireland
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
12/01/2017
Details
247-421-8
26038-87-9
France
Endocrine disruption
Other human toxicity
Persistence
Under development
Under development
No suggestion yet
23/09/2014
Details
205-031-5
131-57-7
Denmark
Endocrine disruption
Under development
Under development
No suggestion yet
01/04/2015
Details
231-512-4
7601-90-3
Germany
Endocrine disruption
Under development
Under development
No suggestion yet
13/06/2016
Details

Export search results to:

Categories Display


Route: .live2